Research & Development
"In our field trial stations, our dedicated technical team develops and evaluates feed solutions the world needs, both for today and for the future."
At Impextraco, we are totally committed to developing innovative products which meet the demands of our wide range of customers operating in highly diverse conditions around the world. We are proud of our in-house labs and several in vivo trial stations which we maintain in Belgium and Brazil. We collaborate with highly skilled university researchers, scientists and farmers to develop and evaluate the feed solutions the world needs, both for today and for the future.
We develop our products based on their in vitro and in vivo efficacy. Because basic lab tests do not always reﬂect field conditions, we are committed to generating and validating different in vitro protocols which mimic what happens in the animal as closely as possible. This is a crucial step in our product development process.
Our poultry in vivo station.
Our R&D department conducts a wide range of product trials on relevant species of livestock such as pigs, poultry and cattle. These in vivo studies are designed and deployed by our team of veterinarians and specialists in different fields.
Our swine in vivo station.
This cooperation allows us to generate results from monofactorial trials which are statistically significant. Our state-of- the-art facilities and experimental units in Belgium and Brazil comply with strict international guidelines. In addition, Impextraco’s R&D team assists in setting up field trials in different regions worldwide in order to simulate our customers’ everyday practice.
By conducting both in vitro and in vivo trials, our R&D team can optimize and extend our existing product range to meet the demands of our customers around the world and accommodate the widely varying conditions in which they operate.
The global spread of COVID-19 and the subsequent extreme measures that countries are implementing to slow down the virus have had and are having a serious impact in all of us.
Impextraco has increased its safety protocols as we continue to monitor the situation closely. This has translated into both an international travel ban for our sales force worldwide and the implementation of home-office policy for all employees whose presence at site was not essential for the daily operation.
Having said that and despite these moments of hardship, our production plant and distribution centers continue to operate at full capacity thanks to our factory team. Similarly, our QA/QC teams are guaranteeing the same high quality standards as usual and last, but not least, our diligent customer service team is assuring the delivery of our products under these exceptional circumstances.
I am a dairy producer in the Americas, with about 2000 cows. My feed company had decided to buy corn of a new supplier and it contained severe toxin loads.
My cows were on 6 g/head/day Elitox® at the time. But they started to show T-2 type signs with bloody diarrhea throughout the herd and several cows died after being removed from the herd to the sick group.